MX2011009679A - Dispositivo de suministro de farmaco zootecnico. - Google Patents
Dispositivo de suministro de farmaco zootecnico.Info
- Publication number
- MX2011009679A MX2011009679A MX2011009679A MX2011009679A MX2011009679A MX 2011009679 A MX2011009679 A MX 2011009679A MX 2011009679 A MX2011009679 A MX 2011009679A MX 2011009679 A MX2011009679 A MX 2011009679A MX 2011009679 A MX2011009679 A MX 2011009679A
- Authority
- MX
- Mexico
- Prior art keywords
- drug delivery
- zoo
- delivery device
- technical
- active substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
La presente invención se refiere a un sistema (dispositivo) de suministro de fármaco zootécnico veterinario para la liberación simultánea de dos o más sustancias activas, en donde el sistema libera las sustancias activas en una relación sustancialmente constante durante un periodo de tiempo prolongado. El sistema de suministro de fármaco puede estar en diferentes formas, tal como por ejemplo, un implante, o un dispositivo intravaginal tal como una bobina helicoidal, resorte o anillo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16093909P | 2009-03-17 | 2009-03-17 | |
EP09155385 | 2009-03-17 | ||
PCT/EP2010/053240 WO2010105995A2 (en) | 2009-03-17 | 2010-03-15 | Zoo-technical drug delivery device |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011009679A true MX2011009679A (es) | 2011-09-30 |
Family
ID=42115744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011009679A MX2011009679A (es) | 2009-03-17 | 2010-03-15 | Dispositivo de suministro de farmaco zootecnico. |
Country Status (10)
Country | Link |
---|---|
US (2) | US9198857B2 (es) |
EP (1) | EP2408423A2 (es) |
AR (1) | AR076123A1 (es) |
AU (1) | AU2010224957B2 (es) |
BR (1) | BRPI1009586A2 (es) |
CA (1) | CA2755828A1 (es) |
MX (1) | MX2011009679A (es) |
UY (1) | UY32492A (es) |
WO (1) | WO2010105995A2 (es) |
ZA (1) | ZA201106668B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS58011B1 (sr) | 2010-03-16 | 2019-02-28 | Titan Pharmaceuticals Inc | Heterogena implantabilna sredstva za isporuku lekova |
PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
US10406336B2 (en) | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
EP3784247A1 (en) * | 2018-04-27 | 2021-03-03 | Evestra, Inc. | Estrogen prodrugs and methods of administering estrogen prodrugs |
CN112137975A (zh) * | 2020-10-30 | 2020-12-29 | 厦门汇承药业有限公司 | 一种烯丙孕素片及其干法制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3417182A (en) | 1963-03-25 | 1968-12-17 | Upjohn Co | Compositions and treatments using 6-methyl - 16 - methylene - 17alpha - hydroxy-4,6-pregnadiene-3,20-dione 17-acetate |
US4472394A (en) | 1983-09-19 | 1984-09-18 | G. D. Searle & Co. | Method for increasing weight in domestic animals |
AU573783B2 (en) * | 1984-01-31 | 1988-06-23 | International Foundation For Biochemical Endocrinology | Method for promoting growth and improved meat quality with female steroidal hormones |
HU203667B (en) | 1986-12-11 | 1991-09-30 | Roussel Uclaf | Process for producing synergetic zootechnical compositions containing three components |
US5147869A (en) | 1986-12-11 | 1992-09-15 | Roussel Uclaf | Zootechnical compositions |
TW358031B (en) | 1997-04-11 | 1999-05-11 | Akze Nobel N V | Drug delivery system for 2 or more active substances |
US7001609B1 (en) * | 1998-10-02 | 2006-02-21 | Regents Of The University Of Minnesota | Mucosal originated drug delivery systems and animal applications |
TWI336627B (en) | 2003-05-23 | 2011-02-01 | Organon Nv | Drug delivery system,and use and manufacturing method thereof |
AU2005224056B2 (en) | 2004-03-24 | 2010-03-18 | Merck Sharp & Dohme B.V. | Drug delivery system based on polyethylene vinylacetate copolymers |
JP2010509964A (ja) | 2006-11-20 | 2010-04-02 | ナームローゼ・フエンノートチヤツプ・オルガノン | らせん形薬物送達システム |
US8741329B2 (en) * | 2007-09-21 | 2014-06-03 | Merck Sharp & Dohme B.V. | Drug delivery system |
-
2010
- 2010-03-15 WO PCT/EP2010/053240 patent/WO2010105995A2/en active Application Filing
- 2010-03-15 BR BRPI1009586A patent/BRPI1009586A2/pt not_active IP Right Cessation
- 2010-03-15 EP EP10710000A patent/EP2408423A2/en not_active Withdrawn
- 2010-03-15 AU AU2010224957A patent/AU2010224957B2/en not_active Ceased
- 2010-03-15 MX MX2011009679A patent/MX2011009679A/es active IP Right Grant
- 2010-03-15 UY UY0001032492A patent/UY32492A/es not_active Application Discontinuation
- 2010-03-15 CA CA2755828A patent/CA2755828A1/en not_active Abandoned
- 2010-03-15 US US13/256,286 patent/US9198857B2/en not_active Expired - Fee Related
- 2010-03-16 AR ARP100100818A patent/AR076123A1/es unknown
-
2011
- 2011-09-12 ZA ZA2011/06668A patent/ZA201106668B/en unknown
-
2015
- 2015-10-22 US US14/919,875 patent/US20160038430A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
UY32492A (es) | 2010-10-29 |
AU2010224957A1 (en) | 2011-09-29 |
CA2755828A1 (en) | 2010-09-23 |
AU2010224957B2 (en) | 2016-07-21 |
US9198857B2 (en) | 2015-12-01 |
WO2010105995A2 (en) | 2010-09-23 |
US20120058171A1 (en) | 2012-03-08 |
ZA201106668B (en) | 2014-03-26 |
WO2010105995A3 (en) | 2011-01-20 |
EP2408423A2 (en) | 2012-01-25 |
US20160038430A1 (en) | 2016-02-11 |
AR076123A1 (es) | 2011-05-18 |
BRPI1009586A2 (pt) | 2016-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011009679A (es) | Dispositivo de suministro de farmaco zootecnico. | |
PL2079446T3 (pl) | Preparat paliperidonu o przedłużonym uwalnianiu | |
EP4233978A3 (en) | Oral delivery of active drug substances | |
IL216468A0 (en) | Compositions, methods & systems for respiratory respiratory delivery of two or more active agents | |
IN2012DN01216A (es) | ||
MX2011007930A (es) | Conjugados de insulina cristalina. | |
WO2010096733A3 (en) | Luminescent porous silicon nanoparticles, methods of making and using same | |
MX2010009043A (es) | Composicion farmaceutica para farmacos poco solubles. | |
IN2012DN00829A (es) | ||
EA201590805A1 (ru) | Композиция с немедленным и пролонгированным высвобождением | |
UA103025C2 (ru) | Твердая композиция лекарственного средства замедленного высвобождения | |
MX359288B (es) | Forma iv del clorhidrato de ivabradina. | |
WO2010120389A3 (en) | Polymeric drug delivery systems and processes for producing such systems | |
TN2012000488A1 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
GB0907019D0 (en) | Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients | |
MX353623B (es) | Sistema de suministro de farmaco. | |
MX344846B (es) | Combinacion de granulos cargados activos con activos adicionales. | |
IN2012DN02793A (es) | ||
EA201400737A1 (ru) | Система доставки на основе множества пеллет с немедленным высвобождением активного вещества | |
EA026830B9 (ru) | Осмотически активная система вагинальной доставки | |
MX2010008852A (es) | Formulaciones de flibanserina. | |
WO2010120817A3 (en) | Nanochanneled device and related methods | |
MX349563B (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
TR200909785A1 (tr) | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. | |
GB201007237D0 (en) | A holder and a method of using the holder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |